- Home
- KOPN vs MNOV Comparison
KOPN vs MNOV Comparison
Compare KOPN & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOPN
- MNOV
- Stock Information
- Founded
- KOPN 1984
- MNOV 2000
- Country
- KOPN United States
- MNOV United States
- Employees
- KOPN N/A
- MNOV N/A
- Industry
- KOPN Semiconductors
- MNOV Biotechnology: Pharmaceutical Preparations
- Sector
- KOPN Technology
- MNOV Health Care
- Exchange
- KOPN Nasdaq
- MNOV Nasdaq
- Market Cap
- KOPN 255.1M
- MNOV 65.7M
- IPO Year
- KOPN 1992
- MNOV 2005
- Fundamental
- Price
- KOPN $2.25
- MNOV $1.24
- Analyst Decision
- KOPN Strong Buy
- MNOV Strong Buy
- Analyst Count
- KOPN 2
- MNOV 2
- Target Price
- KOPN $2.63
- MNOV $7.00
- AVG Volume (30 Days)
- KOPN 3.6M
- MNOV 64.6K
- Earning Date
- KOPN 11-11-2025
- MNOV 11-12-2025
- Dividend Yield
- KOPN N/A
- MNOV N/A
- EPS Growth
- KOPN N/A
- MNOV N/A
- EPS
- KOPN N/A
- MNOV N/A
- Revenue
- KOPN $46,959,478.00
- MNOV $134,599.00
- Revenue This Year
- KOPN N/A
- MNOV N/A
- Revenue Next Year
- KOPN $27.17
- MNOV N/A
- P/E Ratio
- KOPN N/A
- MNOV N/A
- Revenue Growth
- KOPN 13.03
- MNOV N/A
- 52 Week Low
- KOPN $0.56
- MNOV $1.13
- 52 Week High
- KOPN $2.67
- MNOV $2.55
- Technical
- Relative Strength Index (RSI)
- KOPN 55.87
- MNOV 39.86
- Support Level
- KOPN $2.05
- MNOV $1.25
- Resistance Level
- KOPN $2.67
- MNOV $1.38
- Average True Range (ATR)
- KOPN 0.21
- MNOV 0.05
- MACD
- KOPN 0.02
- MNOV -0.01
- Stochastic Oscillator
- KOPN 44.74
- MNOV 5.00
About KOPN Kopin Corporation
Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.